PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $189,000 | +98.9% | 31,817 | +215.0% | 0.01% | +66.7% |
| Q1 2017 | $95,000 | +163.9% | 10,100 | +140.5% | 0.00% | +200.0% |
| Q4 2016 | $36,000 | -98.0% | 4,200 | -98.5% | 0.00% | -97.7% |
| Q3 2016 | $1,822,000 | -81.6% | 287,813 | -87.7% | 0.04% | -79.4% |
| Q2 2016 | $9,885,000 | -4.1% | 2,342,388 | -0.9% | 0.21% | -20.8% |
| Q1 2016 | $10,309,000 | -29.1% | 2,364,488 | -0.3% | 0.26% | -35.3% |
| Q4 2015 | $14,532,000 | +6.2% | 2,370,760 | -0.9% | 0.41% | -11.9% |
| Q3 2015 | $13,683,000 | -23.2% | 2,392,099 | +0.2% | 0.46% | -11.1% |
| Q2 2015 | $17,812,000 | +27.2% | 2,387,708 | +1.9% | 0.52% | +16.3% |
| Q1 2015 | $14,007,000 | -21.8% | 2,342,388 | -1.2% | 0.45% | -28.1% |
| Q4 2014 | $17,921,000 | +46.6% | 2,370,503 | +0.6% | 0.62% | +41.3% |
| Q3 2014 | $12,228,000 | +21.1% | 2,356,092 | +0.6% | 0.44% | +14.0% |
| Q2 2014 | $10,095,000 | +5.4% | 2,342,388 | 0.0% | 0.39% | -4.7% |
| Q1 2014 | $9,580,000 | -23.3% | 2,342,388 | -0.0% | 0.41% | -33.2% |
| Q4 2013 | $12,487,000 | +6.2% | 2,342,795 | +0.0% | 0.61% | +25.6% |
| Q3 2013 | $11,759,000 | +12.6% | 2,342,388 | 0.0% | 0.48% | -38.2% |
| Q2 2013 | $10,447,000 | – | 2,342,388 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|